LUNGevity Foundation is pleased to offer eight lung cancer translational research award programs in 2023:
- LUNGevity’s Career Development Award Program supports future research leaders who will keep the field of lung cancer research vibrant with new ideas. Research that will be funded in 2023 is expected to have a direct impact on the early detection of lung cancer and/or individualized lung cancer treatment, including through targeted therapy and immunotherapy. This is a mentored, three-year $300,000 award.
Learn more
- LUNGevity’s Veterans Affairs Research Scholar Award Program supports investigators interested in lung cancer research within the US Department of Veterans Affairs. Applicants must hold a doctoral degree and either be pursuing a postdoctoral fellowship program or be junior faculty within the first five years of their faculty appointment at the time of application. This is a $100,000 two-year award.
Learn more
- LUNGevity’s Health Equity and Inclusiveness Junior Investigator Award Program supports physician-scientists interested in conducting lung cancer clinical research and bridging health disparities by engaging underserved communities/underrepresented minorities. Applicants must hold a doctoral degree, be within the first five years of their first faculty appointment, and have completed a training fellowship. This is a $200,000 two-year award.
Learn more
- LUNGevity’s Health Equity and Inclusiveness Research Fellow Award Program supports fellows who belong to underrepresented minorities in STEM who are interested in lung cancer research. Applicants must hold a doctoral degree, be pursuing a postdoctoral fellowship, and plan to pursue a career in lung cancer. This is a $100,000 two-year award.
Learn more
- LUNGevity’s Early Detection Research Award Program supports translational research projects directed at new approaches to improve clinical methods for the detection and diagnosis of primary tumors. Applicants must hold a doctoral degree and have a faculty appointment. This is a two- or three-year $600,000 award.
Learn more
- The EGFR Resisters/LUNGevity Research Award Program for EGFR-Positive Lung Cancer funds high-impact research that seeks to transform the future for patients diagnosed with EGFR-positive lung cancer. Projects must directly relate to improvement of patient outcomes and/or lead to a clinical trial. This is a $200,000 two-year award. The program is open to both US and non-US applicants.
Learn more
- The ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant fosters and develops the research careers of residents and fellows interested in radiation oncology-related basic, translational, and/or clinical research to benefit patients with lung cancer. This is a $25,000 one-year award.
Learn more
- The Rising Tide/LUNGevity Team Award Program to Target Mechanisms of Resistance funds high-impact research that seeks to develop therapeutic strategies targeting shared mechanisms of resistance in oncogene-driven lung adenocarcinoma. Applicants must hold a doctoral degree and have a faculty appointment. This is a $1,500,000 three-year team award; the involvement of at least two institutions is required. The program is open to both US and non-US applicants.
Learn more